Demand for Biologics in Japan

Future Market Insights

Key Insight

The demand for biologics in Japan is projected to grow from USD 20.4 billion in 2025 to USD 39.5 billion by 2035, at a CAGR of 6.8%. Monoclonal Antibodies will dominate with a 31.0% market share, while infectious diseases will lead the application segment with a 30.0% share.

December 12, 2025

Anurag Sharma

250 Pages

Cite this Report

Demand for Biologics in Japan

https://www.futuremarketinsights.com/reports/japan-biologics-market

License

Buy Now

Summary ToC Companies

Key Players

The Vanguard Group
Amgen
Eli Lilly and Company
F. Hoffmann-La Roche Ag
GSK

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Demand for Biologics in Japan

Key Players

Similar Industry Reports